Trial intelligence / Profile preview

Immunogenicity of influenza vaccination among breast cancer patients

2015-003106-16Phase 4Active

Sponsor
Antonis Valachis
Start
Oct 2015
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 4, single-arm trial of Fluarix in influenza, sponsored by Antonis Valachis. Primary endpoint: Immunogenicity to influenza vaccination. Started Oct 2015; status: active.

02

Drugs

Fluarix
03

Conditions

influenza

Beyond the preview

Go deeper on 2015-003106-16.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-003106-16.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call